Penile fracture: immediate treatment leads to better long-term results, with a lower incidence of erectile dysfunction and penile curvature


The objective of a study was to review the cases of patients with suspected penile fracture and asses erectile and sexological outcomes.

From 1987 to 2013 a total of 41 cases presented to the Urology Clinic of Trieste and at the AIED of Pordenone; the patients were divided into two groups according to the timing of treatment: 18 patients with anamnestic diagnosis of penile fracture treated nonimmediately and 23 patients treated immediately after the trauma.

The erectile function was evaluated through the IIEF, as well as the psychological impact of the trauma on social and sex life, using a psycho-sexological questionnaire.

Among patients treated immediately after the trauma 14 were subjected to surgery. About a year after surgery, penile curvature was reported in 1 patient, pain in 3 patients, urinary disorders in 1 patient, while none reported erectile dysfunction. Out of these, only 3 patients underwent reoperation.

Among those treated conservatively 1 patient reported curvature, 1 patient reported pain and none reported erectile dysfunction.

Among patients who were admitted at a later date, 14 reported curvature and 4 reported pain whereas urinary disorders were reported in 1 and erectile dysfunction in 4 patients.

From a psychological point of view, the trauma caused in most cases a fear of new trauma and of repercussions on erectile function and sensitivity.

In conclusion, the diagnosis is mainly clinical; however, radiological investigation is essential to confirm the diagnosis, assess the site and extent of the trauma and possible urethral involvement, so as to plan the most appropriate treatment.
In addition, immediate treatment leads to better long-term results, with a lower incidence of erectile dysfunction and penile curvature.
Psychologically, penile trauma intensifies the fear of reoccurrence; it decreases, however, with the passage of time. ( Xagena )

Pavan N et al, Arch Ital Urol Androl 2014;86:359-370

XagenaMedicine2014